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In the face of increasing bacterial resistance to antibiotics currently in use, the search
for new antimicrobial agents has received a boost in recent years, with natural products
playing an important role in this field. In fact, several methods have been proposed to
investigate the antibacterial activities of natural products. However, given that the ultimate
aim is future therapeutic use as novel drugs, it is extremely necessary to elucidate their
modes of action, stating the molecular effects in detail, and identifying their targets in the
bacterial cell. This review analyzes the application of “omics technologies” to understand
the antibacterial mechanisms of bioactive natural products, to stimulate research interest
in this area and promote scientific collaborations. Some studies have been specifically
highlighted herein by examining their procedures and results (targeted proteins and
metabolic pathways). These approaches have the potential to provide new insights into
our comprehension of antimicrobial resistance/susceptibility, creating new perspectives
for the struggle against bacteria, and leading to the development of novel products in
the future.
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INTRODUCTION
The alarming spread of bacterial resistance to antibiotics is one of the most serious challenges to
global public health, as drug resistance has been found for all classes of antibiotics used in clinical
practice (Arias and Murray, 2015). Moreover, few new antibiotic classes have been discovered in
the last several decades. Managing this situation will require extensive search for new drugs and
elucidation of their mechanisms of action (MOA; Kon and Rai, 2012).
In general, natural plant products have been documented as important alternative sources
of new antimicrobial agents. Traditional knowledge regarding the use of medicinal plants has
driven the identification of plant-derived products with different chemical structures (Radulovic
et al., 2013). This structural diversity enables the active phytochemicals to act through diverse
mechanisms (usually targeting multiple biochemical pathways), which are sometimes different
from those used by traditional antibiotics (Simões et al., 2009; Radulovic et al., 2013; Harvey et al.,
2015).
Given the great achievements in the development of analytical tools for identification and
isolation of antimicrobial phytochemicals, the biggest challenge now is the characterization of
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their MOA, which is essential to supporting their use as
lead molecules for drug-development programs (Swinney
and Anthony, 2011). The approaches adopted to identify a
possible drug target are predominantly based on the combined
application of several biochemical and genetic assays (such as
flow cytometry, electron microscopy, colorimetric assays, and
gene expression analysis), using both cellular systems and model
organisms. However, the combination of these techniques takes
time and requires the use of large amounts of the compound
under investigation (Swinney and Anthony, 2011; Schirle et al.,
2012; Sianglum et al., 2012; Roemer and Boone, 2013; Tang,
2015).
Recent advances in “omics” technologies (genomics,
transcriptomics, proteomics, andmetabolomics) are attributed to
innovative breakthroughs in genome sequencing, bioinformatics,
and analytic tools such as liquid and gas chromatography and
mass spectrometry, along with high-throughput technologies.
Omics technologies have provided crucial insights into processes
related to bacterial physiology, virulence, stress, and the MOA
of antimicrobial compounds (Roemer and Boone, 2013; Tang,
2015; Figure 1). The use of these tools provides deeper and more
robust data, and has greater potential to reveal new therapeutic
targets than conventional assays. These new targets and their
related pathways are critically important in the struggle to
overcome drug resistance (Roemer and Boone, 2013). In this
review, we will focus on the application of these methodologies
to study the mechanisms of action of plant-derived antibacterial
compounds.
OVERVIEW OF PHENOTYPICAL METHODS
FOR THE ELUCIDATION OF
ANTIBACTERIAL MOA
Compounds with antibacterial activity are usually selected by
traditional antimicrobial methodologies such as agar-diffusion
based assays, determination of minimum inhibitory (MIC),
and bactericide (MBC) concentrations, and time-kill curves.
Once an antimicrobial candidate is selected, the next step is to
characterize its action on bacterial structures such as the cell
membrane, genetic material, and/or protein synthesis, usually
through phenotypical assays (Gottschalk et al., 2013; Silva et al.,
2013a; Monte et al., 2014; Hyldgaard et al., 2015; Magi et al.,
2015; Gerits et al., 2016; Moreira et al., 2016). Next, the molecular
pathway can be elucidated by analyzing the expression of the
genes related to the phenotype observed (Gottschalk et al., 2013).
Here, we will discuss the methods to evaluate the effects on the
cell membrane, DNA damage, and macromolecular synthesis.
The morphological alterations on cell membrane can
be efficiently studied by electron microscopy (Silva et al.,
2013a). Alternatively, various assays are performed to evaluate
membrane integrity. One simple assay measures the leakage
of cell material that absorbs at 260 nm wavelength on
the supernatant of treated cells. Nucleic acids and related
compounds (such as pyrimidines and purines) havemaxUV light
absorbance at this wavelength. The increase of this material in
the supernatant indicates bacterial cell wall and/or membrane
damage (Chusri and Voravuthikunchai, 2009; Silva et al., 2013b).
Another useful approach is the detection of cytoplasmic enzymes
or ATP leakage in the cell culture supernatant of treated bacteria
(Gottschalk et al., 2013). Fluorescent probes are also widely
used to evaluate membrane viability, such as propidium iodide
(PI), SYTOX green, 1-N-phenylnaphthylamine (NPN), and 3,3′-
diethyloxacarbocyanine iodide [DiOC2(3)]. For example, PI is
used to evaluate membrane integrity, as it is a membrane
impermeant dye that intercalates DNA (only if there is a damage;
Van Nevel et al., 2013); whereas DiOC2(3) helps measure the
membrane potential (Moreira et al., 2016).
Recently, the effects of boromycin (a polyether macrolide
antibiotic isolated from Streptomyces antibioticus) on
mycobacterial cell membrane were evaluated. The authors
adopted an approach where, to assess the release of cell
content, a strain of Mycobacterium bovis was transformed
with a plasmid (pGMEH-P38-mRFP) encoding mCherry Red
Fluorescent Protein (mRFP). After treatment with boromycin,
the fluorescence in the supernatant was measured (Moreira et al.,
2016).
The action of a compound on DNA integrity can be evaluated
by DNA-binding analysis, in which a sample of purified DNA
(usual plasmid DNA) is mixed with different concentrations of
the tested compound. After an incubation period, the reaction
is subjected to electrophoretic analysis. From the gel retardation
assay, interference on the migration profile in relation to control
cells is considered a positive result (the compound can bind to
the DNA; Gottschalk et al., 2013). DNA fragmentation induced
by an antimicrobial can be detected in situ by TUNEL (terminal
deoxynucleotidyl transferase mediated dUTP nick end labeling)
assay. Usually this assay employs fluorescently tagged dUTP,
which binds to 3′-OH groups in DNA breaks (Rohwer and
Azam, 2000). Difference in DNA distribution between treated
and untreated cells can be analyzed using DAPI dye (4′,6-
diamidino-2-phenylindole; Kjelstrup et al., 2013). Damage of
bacterial DNA induces formation of the RecA filament, leading
to auto-cleavage of LexA resulting in activation of SOS response.
In this sense, perturbations in DNA integrity can be indirectly
assessed through the expression of recA gene (Gottschalk et al.,
2013; Kjelstrup et al., 2013).
To investigate the effects of a compound on bacterial
macromolecular synthesis, a scintillation assay can be performed.
In this assay, bacterial culture is labeled by the addition of
radioactive precursors of DNA ([methyl-3H]thymidine), RNA
([5,6-3H]uridine), or protein (L-[G-3H]glutamine) synthesis.
After the experimental treatment, the radiolabeled incorporation
is measured using a scintillation counter (Gottschalk et al., 2013;
Kjelstrup et al., 2013; Gerits et al., 2016).
GENOMICS AND ADVANCES IN
ANTIBIOTICS RESEARCH
The advent of efficient genetic sequencing technologies enabled
the complete decoding of various microbial genomes, making all
this information accessible. This resulted in the identification of a
range of genes related to essential processes for bacterial survival,
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FIGURE 1 | Overview of applications of “omics technologies” to evaluate the mechanisms of action of natural antimicrobials (NAM). (A) Genomic
approaches: the target can be discovered by comparing the DNA sequence of a NAM-resistant bacteria and normal bacteria. (B) Proteomic and transcriptomic
approaches: target identification can be performed by evaluating differential expression of genes in strains treated or untreated with NAM. (C) Metabolomic analysis:
the metabolic profile of a bacterium treated with NAM can be compared with the profile of different drugs with known actions, potentially leading to target identification.
virulence, and mutagenesis. These genes and their products
are therefore potential new antimicrobial targets (Roemer and
Boone, 2013; Scheﬄer et al., 2013). This knowledge is of utmost
importance to the development of new screening platforms
for identification and selection of compounds targeting specific
essential genes based on protein interactions andmutant libraries
(Zhang et al., 2015; Morita et al., 2016). A classical approach,
applicable to select compounds that are able to interact with a
specific target, is based on affinity chromatography systems. In
these assays, the target can be immobilized on a matrix (affinity
matrix), and a bioactive compound that is able to bind the target
can be isolated and identified (Sakamoto et al., 2012).
The interaction of a target and bioactive compound can also
be evaluated using bacterial two-hybrid (BTH) systems. Several
BTH platforms have been engineered, such as the BTH assay
based on adenylate cyclase (cya) reconstitution. This system was
comprehensively revised by Battesti and Bouveret (2012). Briefly,
the adenylate cyclase from Bordetella pertussis is divided in two
sub-domains (T18 and T25), and each gene encoding the proteins
of interest is cloned into a vector fused to either T18 or T25
protein fragments. The vector is inserted in an Escherichia coli
strain lacking endogenous cya (cya−). The interaction between
the proteins of interest brings into proximity the T18 and
T25 fragments and a Cya+ phenotype is created. This results
in cyclic adenosine monophosphate (cAMP) production and
consequently, in the activation of cAMP-regulated promoters
(e.g., the lac promoter). A BTH based on cya activity was
employed by Kjelstrup et al. (2013) to select compounds capable
of disrupting the interaction between proteins involved in DNA
replication of Staphylococcus aureus. The authors found two
peptide inhibitors of the dimerization of the β-sliding clamp of
the replisome.
Another system developed from genomic technologies is
based on the screening of a genome-wide mutant library
(Gray et al., 2015). These mutants can be generated through
mutagenesis mediated by mobile genetic elements such as
transposons (Pasquina et al., 2015; Gerits et al., 2016). Next,
mutants with altered sensitivity to the compound are identified,
elucidating the pathways involved in its action (through genomic
studies). This approach was adopted to elucidate the molecular
mechanism of alfalfa snakin-1 (MsSN1), an antimicrobial peptide
produced by Medicago sativa, against Pseudomonas fluorescens
Pf-5. This work revealed that MsSN1 peptide acts on adhesion
properties of P. fluorescens (Ayub et al., 2015; Table 1).
Sequencing methods can also be applied in the discovery of
potential targets through the selection of mutants resistant to
the new compound, followed by genetic comparison (Brazas
and Hancock, 2005; Bachmann et al., 2014; Köser et al.,
2014). In this case, the wild type strain is cultivated in
the presence of the antimicrobial compound, and mutants
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can be generated by natural selection. This strategy can be
exemplified by the elucidation of the antibacterial action
mechanism of a new compound designated SPI031 [N-alkylated
3, 6-dihalogenocarbazol 1-(sec-butylamino)-3-(3,6-dichloro-9H-
carbazol-9-yl)propan-2-ol] against P. aeruginosa. The authors
selected three SPI031-resistant mutants and compared their
whole genome sequences with the genome of P. aeruginosa wild-
type (WT). They found mutations in the genes coding for the
multidrug eﬄux pump (nfxB) and outer membrane synthesis
(htrB and PA14_23400; Gerits et al., 2016). This approach has the
advantage of being able to overcome the limitations of protein
interaction assays or mutant libraries in revealing new targets
(Nijman, 2015).
TRANSCRIPTOMICS TECHNOLOGIES IN
ANTIBIOTIC RESEARCH
Several studies support that theMOA of an antibiotic is related to
the interaction of multiple pathways (Dwyer et al., 2015). Thus,
techniques for the analysis of gene expression on a large scale
(transcriptional analysis) have been widely applied to evaluate
the action mechanisms of an antibiotic, including those derived
from plants. These assays are classified as “transcriptomics,”
which is a set of high-throughput technologies that analyze the
transcriptome (the complete set of RNA transcripts produced by
an organism or cell under specific circumstances; Nambiar et al.,
2010).
Currently, DNA microarrays are the technology of choice for
large-scale studies of gene expression. Microarray technology
was developed using the information available from the
genome projects and is based on the hybridization of cDNA
(complementary DNAproduced frommRNA) to oligonucleotide
probes incorporated into a slide. Each probe has a sequence of a
specific gene from the organism. Microarrays have the advantage
of simultaneously measuring the global gene expression at the
level of transcription, and thus providing insights into the
molecular pathways related with the investigated phenomena.
Generally, at least two different experimental situations are
studied and the cDNA extracted from each is labeled with
different fluorophores (Smith et al., 2005; Nagaraj and Singh,
2010). Microarrays have been used to elucidate the MOA
of several phytochemicals, opening new insights into the
modulation of different pathways caused by an antimicrobial
agent (Hammami and Fliss, 2010; Chung et al., 2013; Wei
et al., 2014; Eng and Nathan, 2015; Shen et al., 2015). We
highlight some of them herein, with more examples provided in
Table 1.
Licochalcone A is a chalcone isolated from Glycyrrhiza inflata
(Fabaceae), which shows different pharmacological activities,
including the inhibition of S. aureus biofilm formation and
planktonic cells. The transcriptional profile of this pathogen
treated with licochalcone A was evaluated by a microarray assay.
Several genes had their expression significantly altered after
licochalcone A treatment, especially those related to autolysis, cell
wall, pathogenic factors, protein synthesis, and capsule synthesis
(Shen et al., 2015).
Another example is a study carried out to evaluate the
molecular effects triggered by lupulone (phenolic acid from
Humulus lupulus) in Mycobacterium tuberculosis. The authors
reported that 540 genes were found to be differentially regulated,
which were involved in various pathways such as surface-exposed
lipids, cytochrome P450 enzymes, PE/PPE multigene families,
ABC transporters, and protein synthesis (Wei et al., 2014).
Pentacyclic triterpenoids (such as α-amyrin, betulinic acid,
and betulinaldehyde) are phytochemicals with recognized
anti-S. aureus action. The transcriptional changes induced
by sub-inhibitory doses of these three components in
a methicillin-resistant S. aureus strain were analyzed by
microarray, showing that they act by targeting pathways such
as cell division (FtsZ), ABC transporters (OPP-1C), fatty acid
(fabz), and peptidoglycan (fmhB, PBP2) biosynthesis, DNA
replication (ccrA), two-component regulatory system, and
β-lactam resistance (mecR1). The proposed MOA was the
inhibition of cell growth by destabilization of the bacterial cell
membrane combined with the cessation of protein and fatty
acids synthesis (Chung et al., 2013).
Transcriptional analysis bymicroarrays and other gene probe-
based methods are relatively inexpensive and compatible with
high-throughput studies. However, these methods have some
limitations, such as the availability of arrays for a particular
species (the target species needs to have a sequenced genome),
and technical issues including reproducibility. Specifically for
bacterial studies (or for other highly variable genomes), another
discovered issue is that the array is designed using genomic
information of a wild type strain and cannot detect genes present
only in a particular isolate (Wang et al., 2009; Bumgarner,
2013; Dopazo, 2014; Zhao et al., 2014). These factors together
make sequence-based approaches an interesting alternative
for measuring gene expression. These methods quantify gene
expression directly through sequencing the cDNA produced
from a fragment that maps transcript. The most recent sequence-
based method, RNA sequencing (RNA-Seq), employs recently
developed technologies, providing a deeper quantification of
gene expression (Rapaport et al., 2013).
RNA-Seq studies have been performed to evaluate theMOA of
some plant-derived products (Table 1). For example, this method
was employed to analyze the molecular pathways involved in
the action of ursolic acid and resveratrol against the biofilm
produced by methicillin-resistant S. aureus (Qin et al., 2014).
Ursolic acid is a pentacyclic triterpenoid found in numerous
classes ofmedicinal plants (Kashyap et al., 2016). The anti-biofilm
action of ursolic acid was found to be related to a reduction
in the expression of genes involved in amino acid metabolism
and adhesin expression (Qin et al., 2014). Conversely, resveratrol
(a polyphenol found in red wine) was found to act through
the inhibition of pathways related to quorum sensing, surface
proteins, and capsular polysaccharides (Qin et al., 2014).
PROTEOMICS ASSAYS
Proteomics is the systematic evaluation of all proteins expressed
by one particular cell, tissue, biological fluid, or organism in a
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given time period. It is used to identify and quantify proteins
involved in a particular biological condition, and can also
be applied to determine post-translational modifications, as
well as cellular origin and place of action (Yates et al., 2009).
The first proteomic studies were performed using gels to
separate proteins. In the most commonly applied technique,
two-dimensional electrophoresis (2-DE), proteins are separated
according to their isoelectric points and then separated by their
molecular weights. Thus, maps are created for each sample,
where each spot corresponds to a protein or a small protein
group. Using these maps, different conditions can be studied
and compared through differential protein expression (up
or downregulated; Zhu et al., 2003). To increase sensitivity
and reproducibility, 2DE assays using fluorescence have been
developed (differential electrophoresis; DIGE). This technique
is robust because it allows the simultaneous analysis of more
than one condition (multiplex), excluding the necessity of
experimental replicates, and because fluorophores can detect
protein concentrations more precisely than traditional methods
(Coomassie blue and silver nitrate; Vranakisa et al., 2013).
Proteomic assays are also performed to characterize and quantify
post-translational modifications (PTM), which are essential for a
range of protein functions, including infectious processes (Olsen
and Mann, 2013). PTMs are detected by enrichment techniques
using affinity antibodies, ionic interaction, or by specific enzymes
(Zhao and Jensen, 2009).
Indeed, proteomic approaches have not been adopted in
abundance in the study of the antibacterial MOAs of plant-
derived compounds. A few examples are summarized in
Table 1. In a recent study, the effects of tea polyphenols
(TP; a mix of polyphenols extracted from green tea with a
broad spectrum of bacterial activity) on protein expression
in P. aeruginosa and Serratia marcescens were investigated by
2-DE and MALDI-TOF/TOF analyses. The results confirmed
that the metabolic disorder caused by treatment with TP
was associated with an increase in the amount of membrane
proteins, such as chaperones and key enzymes involved in the
control of membrane component biosynthesis pathways. These
data supported a possible MOA for TP: increased membrane
permeability leading to release of cellular components (Yi et al.,
2010, 2014).
Plumbagin (naphthoquinone) is a yellow natural compound
extracted from the Plumbago zeylanica L. root, which is widely
used in traditional medicine in India and China. The antibacterial
effect of plumbagin on Bacillus subtilis was evaluated by
two complementary proteomic techniques, 2-DE and iTRAQ,
which identified differential expression for 230 proteins, mainly
involved in the citric acid cycle and heme biosynthesis. These
results indicated that plumbagin blocks energy generation and
also suppresses fatty acid biosynthesis. Repression of proteins
directly linked to cell division (FTSA and SpoVG) was also
observed (Reddy et al., 2015). Another example is the elucidation
of the MOA for the alkaloid roemerine from Papaver rhoeas
against E. coli, which was related to the inhibition of membrane
permeability and sugar transporter proteins (Gokgoz and
Akbulut, 2015).
The MOA of rhodomyrtone (isolated from Rhodomyrtus
tomentosa) against methicillin-resistant S. aureus was also
studied by 2-DE analysis, which revealed that this compound
affects the expression of major classes of proteins involved
in cell wall biosynthesis, cell division, protein degradation,
stress response, virulence factors, energy production, and
macromolecules biosynthesis (Sianglum et al., 2011). Another
similar work showed that rhodomyrtone affected enzymes
associated with major metabolic pathways of Streptococcus
pyogenes, apart from its inhibitory actions on virulence
genes, glyceraldehyde-3-phosphate dehydrogenase, cAMP, and
streptococcal pyrogenic exotoxin C (Limsuwan et al., 2011).
These works provided important insights into the antibacterial
activity of this new natural compound, a promising candidate for
a therapeutic agent against bacterial infections.
METABOLOMICS ANALYSES
The last “omics” technology to be presented in this review is
metabolomics, which is defined as the study of the global profile
of metabolites present in a biological system under certain
conditions and time (Nambiar et al., 2010). “Metabolites” is a
general term for a range of end products of cellular processes that
belong to different classes, such as organic acids, amino acids,
fatty acids, sugars, sugar alcohols, steroids, nucleic acid bases,
etc. (Goodacre et al., 2004). Metabolomics analysis investigates
biochemical disturbances caused by disease, drugs, toxins, and
other factors such as genetic modification, etc. (Monteiro et al.,
2013). The development of analytical and data mining methods
is responsible for the quick evolution in the metabolomics field,
providing more insights into cellular organization (Dunn et al.,
2011). Themethods followed to generatemetabolic signatures are
usually nuclear magnetic resonance (NMR), gas chromatography
(GC), liquid chromatography (LC) coupled to mass spectrometry
(LC/MS), capillary electrophoresis coupled to mass spectrometry
(CE-DM), ultra performance liquid chromatography coupled
to mass spectrometry (UPLC/MS), high-performance liquid
chromatography-electrospray ionization coupled to mass
spectrometry (HPLC-ESI/MS), high-performance liquid
chromatography-diode array detection-electrospray ionization
tandem mass spectrometry (HPLC/DAD/ESI-MS; Zhang
et al., 2012). Multivariate analysis of statistical data needs to
be performed owing the complexity of interpreting the data
resulting from an analysis based on the metabolome. Principal
component analysis (PCA) is the most prevalent method
followed to reduce the dimensionality of the data, although
other data mining techniques are routinely applied, such as
clustering algorithms. By PCA, the data obtained are structured
in a two/three-dimensional scores plot where the clustering of
samples is shown in either similar or different groupings (Cox
et al., 2014).
Metabolomics approaches have been widely adopted
to investigate the responses of microorganisms to various
environmental stressors such as heavy metals, temperature,
and organic compounds (Lankadurai et al., 2013), and they
are suitable tools for the study of metabolism disorders in
microorganisms treated with antibiotics (Aliferis and Jabaji,
2011). Conversely, the application of metabonomic approaches
for the discovery of plant-derived compound mechanisms
of action is still largely unexplored, with S. aureus the most
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studied for this purpose (Table 1). In general, the metabolic
profile induced by the tested compound is compared with those
obtained using antibiotics with known action mechanisms. For
example, the anti-S. aureus action of Aquilegia oxysepala extract
(used in traditional Chinese medicine) and its main chemical
components (genkwanin, apigenin, maguoflorine, and berberine)
were investigated by metabonomics (HPLC/DAD/ESI-MS
analysis combined with PCA) and compared with the profile
induced by nine antibiotics with known modes of action.
This study has shown that the A. oxysepala target should be
similar to those of protein synthesis inhibitors (lincolmensin,
erythromycin, chloromycetin, streptomycin, and acheomycin),
and maguoflorine was the main component responsible for
antibacterial activity (Yu et al., 2007a). In this study, berberine
showed the same effects as rifampicin and norfloxacin, which are
drugs that target nucleic acids (Yu et al., 2007a).
Similarly, the intracellular metabolic profiles of S. aureus
treated with rhizome extract from Tinospora capillipes and
its main constituents (columbin, palmatine, tinoside, and
jatrorrhizine) were studied by HPLC-ESI/MS, showing the
inhibition of RNA polymerase, gyrase, and topoisomerase IV
as targets (similar to rifampicin and norfloxacin). Palmatite
and jatrorrhizine were the most active compounds (Yu et al.,
2007b). However, these metabolomic strategies, which compare
the metabolic profiles of phytochemicals with known antibiotics,
may be somewhat limited because they cannot be applied to
define a new mechanism of action, but are viable and unexplored
alternatives to assign known mechanisms to new bioactive
compounds.
An interesting approach to be explored is the study of the
exometabolome (metabolites that are secreted into the culture
medium). Birkenstock et al. (2012), applying an exometabolome
profiling approach, revealed that triphenylbismuthdichloride
affects bacterial pyruvate catabolism, leading to the discovery
of this compound as an efficient and non-competitive inhibitor
of the bacterial pyruvate dehydrogenase complex. This study
illustrates that metabolomics may represent a promising strategy
to elucidate the MOA of bioactive compounds, and for
combating multidrug-resistant bacteria.
CONCLUSIONS
Taking into account all the possibilities provided by “omics”
technologies, these approaches offer very exciting opportunities
to elucidate the antimicrobial mechanisms of plant-derived
compounds. These studies are essential for the use of the most
promising compounds as therapeutic agents, and they could
also lead to the identification of new targets, owing to the
high degree of structure diversity found in phytochemicals. As
shown in Table 1, there is a diversity of pathways involved
in the MOA of plant-derived antimicrobial compounds. The
design of new antibiotics with different action modes and
structures will be also driven by these studies, and thus
cross-resistance events will be avoided and development of
resistance to these novel compounds will be delayed. It is also
expected that, upon knowledge of the molecular mechanism,
only compounds that have targets unrelated to host factors
will be selected. Nevertheless, some barriers still need to be
overcome prior to the widespread popularization for “omics”
approaches, such as operating cost, complexity, and the
wide dynamic range of the samples, which are being solved
by the constant improvements made in the field and in
bioinformatics technology. An integrated study using different
“omics” technologies would be the ideal approach to elucidate
the MOA of a natural compound since each technique has
particularities with respect to its limitations and the potential of
providing responses.
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